mazindol has been researched along with 6-methyl-2-(phenylethynyl)pyridine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Amalric, M; Baunez, C; Breysse, N; Gasparini, F; Spooren, W | 1 |
1 other study(ies) available for mazindol and 6-methyl-2-(phenylethynyl)pyridine
Article | Year |
---|---|
Chronic but not acute treatment with a metabotropic glutamate 5 receptor antagonist reverses the akinetic deficits in a rat model of parkinsonism.
Topics: Animals; Behavior, Animal; Catalepsy; Corpus Striatum; Excitatory Amino Acid Antagonists; Kinetics; Male; Mazindol; Motor Activity; Oxidopamine; Parkinsonian Disorders; Pyridines; Rats; Rats, Sprague-Dawley; Rats, Wistar; Receptor, Metabotropic Glutamate 5; Receptors, Metabotropic Glutamate; Time Factors | 2002 |